Nectar Lifesciences Limited — Others, 21-11-2024: Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Nectar Lifesciences Ltd. has disclosed details regarding a litigation involving a potential reversal of Input Tax Credit (ITC) amounting to ₹1.02 crore if a case ruled against them. The dispute arises from an order issued by the Assistant Commissioner related to excess ITC claimed during FY 2021-22. The company plans to appeal to the Commissioner (Appeals). This situation could impact the company’s financials if the appeal is unsuccessful, potentially affecting investor confidence. Investors should consider this a neutral impact, weighing it against ongoing operational performance and legal strategies.